🔗 Share this article

Chancellor Rachel Reeves has revealed she is planning "specific action to tackle household expense pressures" in next month's financial statement.

During an interview with the BBC, she stated that lowering price rises is a joint responsibility of both the administration and the Bank of England.

The United Kingdom's price growth is forecast to be the highest among the Group of Seven developed nations this calendar year and the following year.

Potential Utility Cost Measures

Sources suggest the administration could intervene to reduce utility costs, for example by cutting the present 5% rate of value-added tax applied on energy.

A further possibility is to reduce some of the regulatory levies presently included in household expenses.

Fiscal Limitations and Analyst Predictions

The administration will obtain the next report from the independent fiscal watchdog, the OBR, on the start of the week, which will reveal how much scope there is for these actions.

The expectation from most analysts is that Reeves will have to declare higher taxes or expenditure reductions in order to adhere to her self-imposed fiscal targets.

Previously on the same day, calculations indicated there was a £22 billion gap for the chancellor to address, which is at the lower end of projections.

"It is a collective responsibility between the central bank and the administration to further reduce some of the sources of price increases," Reeves stated to the BBC in the US capital, at the yearly gatherings of the IMF and World Bank.

Tax Commitments and Global Issues

While a great deal of the focus has been on expected tax rises, the chancellor said the most recent figures from the OBR had not altered her vow to election pledges not to increase rates on earnings tax, VAT or social security contributions.

She attributed an "uncertain global environment" with rising international and commercial tensions for the fiscal tax moves, likely to be focused on those "most able to pay."

Global Economic Tensions

Addressing concerns about the United Kingdom's trade ties with China she said: "The UK's security interests invariably come first."

Last week's declaration by China to strengthen trade restrictions on critical minerals and other resources that are essential for high-technology manufacturing led American leader Donald Trump to threaten an additional 100% import tax on imports from the Asian country, raising the risk of an full-scale commercial conflict between the two largest economies.

The American finance chief labeled the Chinese move "commercial pressure" and "a international production control attempt."

Asked about accepting the American proposal to participate in its battle with the Asian nation, the Chancellor said she was "deeply worried" by China's measures and encouraged the Chinese government "not to put up barriers and limit trade."

She said the action was "harmful for the international commerce and causes additional headwinds."

"It is my opinion there are areas where we need to confront China, but there are also valuable prospects to trade with Chinese markets, including banking sector and other sectors of the economy. We've got to maintain that balance right."

The chancellor also affirmed she was collaborating with other major economies "on our own essential resources approach, so that we are more independent."

NHS Medicine Pricing and Funding

Reeves also acknowledged that the cost the NHS spends on pharmaceuticals could rise as a consequence of current discussions with the US government and its pharmaceutical firms, in return for lower tariffs and investment.

Some of the biggest global drug companies have said in recent statements that they are either delaying or canceling projects in the United Kingdom, with several attributing the modest returns they are getting.

Recently, the Science Minister said the price the NHS spends on drugs would have to go up to stop companies and pharmaceutical investment leaving the UK.

The Chancellor told media: "It has been observed due to the cost structure, that medical research, recent pharmaceuticals have not been provided in the United Kingdom in the way that they are in other European countries."

"We want to make sure that patients getting treatment from the National Health Service are able to access the best critical medicines in the globe. And so we are examining these issues, and... seeking to secure increased funding into the UK."